Stay updated on DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma

Sign up to get notified when there's something new on the DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma page.
Latest website image capture
Clouds background image

Latest updates to the DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma page

  1. Check
    5 days ago
    Change Detected
    Summary
    Removed references to 'Multiple Myeloma' and to 'MedlinePlus Genetics' from the page's related topics. This reduces explicit disease context and cross-links that help users discover and understand the study.
    Difference
    0.2%
    Check dated 2026-03-26T03:29:18.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Added related topics for Multiple myeloma and MedlinePlus Genetics, and updated the page revision from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-18T22:50:51.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The site footer revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T20:08:02.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Removed the 'Multiple myeloma' condition and the related topic 'MedlinePlus Genetics' from the page.
    Difference
    0.2%
    Check dated 2026-03-04T15:25:11.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Added related topics: Multiple myeloma and MedlinePlus Genetics to the page's related topics section.
    Difference
    0.2%
    Check dated 2026-02-25T10:39:47.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Deleted mentions of 'Multiple myeloma' and the 'MedlinePlus Genetics' related topics. The page loses explicit disease context and a related resources link.
    Difference
    0.2%
    Check dated 2026-02-18T07:53:24.000Z thumbnail image

Stay in the know with updates to DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma

Enter your email address, and we'll notify you when there's something new on the DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma page.